VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
AMWLAmerican Well Corporation
$8.43$141M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

AMWL logoAmerican Well Corporation(AMWL)Earnings, Financials & Key Ratios

AMWL•NYSE
Price updated Jun 19, 2026
SectorHealthcareIndustryHealthcare ITSub-IndustryVirtual Care and Digital Programs
AboutAmerican Well Corporation operates as a telehealth software company that enables digital delivery of care for healthcare. The company products offer urgent care; scheduled visits; acute behavioral health; telestroke; pediatrics; retail health, school health, and home settings. Its application offers urgent care; pediatrics; therapy; menopause nutrition; end-stage renal disease and dialysis; dermatology care; behavioral health therapy; and musculoskeletal care. The company also provides telemedicine equipment, including telemedicine carts, peripherals, tyto care, TV kits, tablets, and kiosks. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.Show more
  • Revenue$249M-2.0%
  • EBITDA-$71M+61.4%
  • Net Income-$96M+54.0%
  • EPS (Diluted)-5.96+57.1%
  • Gross Margin53.29%+37.0%
  • EBITDA Margin-28.6%+60.6%
  • Operating Margin-42.22%+50.6%
  • Net Margin-38.38%+53.1%
  • ROE-33.93%+35.1%

AMWL Key Insights

American Well Corporation (AMWL) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Company is almost debt free
  • ✓Strong 5Y profit CAGR of 15.7%
  • ✓Momentum leader: RS Rating 93 (top 7%)
  • ✓Trading at only 0.5x book value

✗Weaknesses

  • ✗Negative free cash flow

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when AMWL posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

AMWL Price & Volume

American Well Corporation (AMWL) stock price & volume — 10-year historical chart

Loading chart...

AMWL Growth Metrics

American Well Corporation (AMWL) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years0.33%
3 Years-3.47%
TTM-30.26%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM43.21%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM46.81%

Return on Capital

10 Years-34.78%
5 Years-42.62%
3 Years-58.72%
Last Year-36.6%

AMWL Recent Earnings

American Well Corporation (AMWL) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 7/12 qtrs (58%)●Beat Revenue 7/12 qtrs (58%)
Q2 2026Latest
May 5, 2026
Metric
Actual
Est
EPS
$0.78-1.3%
$0.77
Rev
$55M+6.5%
$52M
Q1 2026
Feb 12, 2026
Metric
Actual
Est
EPS
$1.43+10.1%
$1.59
Rev
$55M+5.1%
$53M
Q4 2025
Nov 4, 2025
Metric
Actual
Est
EPS
$1.74-19.4%
$1.46
Rev
$56M+3.2%
$55M
Q3 2025
Aug 5, 2025
Metric
Actual
Est
EPS
$1.24+32.6%
$1.84
Rev
$71M+15.4%
$61M
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 5, 2026
$0.78vs $0.77-1.3%
$55Mvs $52M+6.5%
Q1 2026Feb 12, 2026
$1.43vs $1.59+10.1%
$55Mvs $53M+5.1%
Q4 2025Nov 4, 2025
$1.74vs $1.46-19.4%
$56Mvs $55M+3.2%
Q3 2025Aug 5, 2025
$1.24vs $1.84+32.6%
$71Mvs $61M+15.4%
Based on last 12 quarters of dataView full earnings history →

AMWL Peer Comparison

American Well Corporation (AMWL) competitors in Virtual Care and Digital Programs — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
TDOC logoTDOCTeladoc Health, Inc.Direct Competitor1.46B8.07-7.08-1.54%-6.81%-12.37%0.75
DOCS logoDOCSDoximity, Inc.Direct Competitor3.83B20.4620.8813.05%30.4%19.36%0.01
HIMS logoHIMSHims & Hers Health, Inc.Direct Competitor7.79B35.4769.5559%-0.56%-2.48%2.34
OPRX logoOPRXOptimizeRx CorporationDirect Competitor93.45M4.9818.4418.78%6.37%5.47%0.20
TALK logoTALKTalkspace, Inc.Product Competitor872.74M5.21130.2522%0.49%1.03%
CLOV logoCLOVClover Health Investments, Corp.Product Competitor2.59B5.00-29.4140.34%-2.58%-17.08%
GDRX logoGDRXGoodRx Holdings, Inc.Product Competitor922.03M2.6631.180.57%3.74%4.75%0.10
PRVA logoPRVAPrivia Health Group, Inc.Product Competitor2.98B23.67131.5022.26%0.97%0.01%0.01

Compare AMWL vs Peers

American Well Corporation (AMWL) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs TDOC

Most directly comparable listed peer for AMWL.

Scale Benchmark

vs WELL

Larger-name benchmark to compare AMWL against a more recognizable public peer.

Peer Set

Compare Top 5

vs TDOC, DOCS, HIMS, OPRX

AMWL Income Statement

American Well Corporation (AMWL) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricDec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Sales/Revenue
113.95M148.86M245.26M252.79M277.19M259.05M254.36M249.32M182.49M
Revenue Growth %
-30.63%64.77%3.07%9.65%-6.55%-1.81%-1.98%-30.26%
Cost of Goods Sold
58.61M79.98M156.79M148.47M160.42M164.29M155.41M116.47M111.81M
COGS % of Revenue
51.43%53.73%63.93%58.73%57.87%63.42%61.1%46.71%-
Gross Profit
55.34M▲ 0%
68.88M▲ 24.5%
88.47M▲ 28.4%
104.31M▲ 17.9%
116.77M▲ 11.9%
94.76M▼ 18.8%
98.95M▲ 4.4%
132.86M▲ 34.3%
70.68M▲ 0%
Gross Margin %
48.57%46.27%36.07%41.27%42.13%36.58%38.9%53.29%38.73%
Gross Profit Growth %
-24.46%28.45%17.9%11.94%-18.85%4.42%34.27%-
Operating Expenses
110.45M163.59M315.91M283.46M392.62M786.9M316.49M238.13M217.85M
OpEx % of Revenue
96.92%109.89%128.8%112.13%141.64%303.77%124.42%95.51%-
Selling, General & Admin
68.85M101.88M221.34M160.78M227.98M213.1M197.45M131.31M120.99M
SG&A % of Revenue
60.42%68.44%90.25%63.6%82.25%82.27%77.62%52.67%-
Research & Development
36.27M53.94M84.41M106.59M138.49M105.83M86.06M72.86M63.14M
R&D % of Revenue
31.83%36.24%34.42%42.17%49.96%40.85%33.84%29.22%-
Other Operating Expenses
5.33M7.76M10.15M16.09M26.15M467.97M32.98M33.96M4M
Operating Income
-55.11M▲ 0%
-94.7M▼ 71.9%
-227.43M▼ 140.1%
-179.15M▲ 21.2%
-275.85M▼ 54.0%
-692.14M▼ 150.9%
-217.53M▲ 68.6%
-105.27M▲ 51.6%
-92.29M▲ 0%
Operating Margin %
-48.36%-63.62%-92.73%-70.87%-99.52%-267.19%-85.52%-42.22%-50.57%
Operating Income Growth %
--71.86%-140.15%21.23%-53.98%-150.91%68.57%51.61%-
EBITDA
-49.78M-86.94M-217.28M-163.06M-249.69M-660.63M-184.56M-71.31M-58.56M
EBITDA Margin %
-43.68%-58.41%-88.59%-64.5%-90.08%-255.02%-72.56%-28.6%-32.09%
EBITDA Growth %
--74.67%-149.91%24.95%-53.13%-164.58%72.06%61.36%58.28%
D&A (Non-Cash Add-back)
5.33M7.76M10.15M16.09M26.17M31.51M32.98M33.96M33.72M
EBIT
-55.11M-94.7M-227.43M-179.15M-275.85M-255.66M-217.53M-105.27M-74.86M
Net Interest Income
2.79M5.54M1.63M120K6.12M19.42M10.76M3.8M1.48M
Interest Income
2.79M5.54M1.63M120K6.12M19.42M10.76M3.8M1.48M
Interest Expense
00000000313K
Other Income/Expense
2.79M5.54M-556K-3.01M3.85M16.83M7.65M10.74M5.46M
Pretax Income
-52.31M▲ 0%
-89.17M▼ 70.5%
-227.99M▼ 155.7%
-182.16M▲ 20.1%
-272.01M▼ 49.3%
-675.31M▼ 148.3%
-209.89M▲ 68.9%
-94.53M▲ 55.0%
-86.83M▲ 0%
Pretax Margin %
-45.91%-59.9%-92.96%-72.06%-98.13%-260.69%-82.51%-37.92%-47.58%
Income Tax
0-803K639K-5.38M64K3.86M2.75M434K-351K
Effective Tax Rate %
0%0.9%-0.28%2.95%-0.02%-0.57%-1.31%-0.46%0.4%
Net Income
-52.67M▲ 0%
-87.19M▼ 65.5%
-224.43M▼ 157.4%
-176.33M▲ 21.4%
-270.43M▼ 53.4%
-675.16M▼ 149.7%
-208.14M▲ 69.2%
-95.7M▲ 54.0%
-87.88M▲ 0%
Net Margin %
-46.22%-58.57%-91.51%-69.76%-97.56%-260.63%-81.83%-38.38%-48.16%
Net Income Growth %
--65.53%-157.41%21.43%-53.36%-149.66%69.17%54.02%43.21%
Net Income (Continuing)
-52.31M-88.37M-228.63M-176.78M-272.07M-679.17M-212.64M-94.97M-87.5M
Discontinued Operations
000000000
Minority Interest
27.43M26.26M22.07M21.62M19.97M15.97M11.47M12.21M12.79M
EPS (Diluted)
-25.96▲ 0%
-42.39▼ 63.3%
-45.32▼ 6.9%
-13.88▲ 69.4%
-19.68▼ 41.8%
-47.50▼ 141.4%
-13.88▲ 70.8%
-5.96▲ 57.1%
-5.30▲ 0%
EPS Growth %
--63.29%-6.91%69.37%-41.79%-141.36%70.78%57.06%46.81%
EPS (Basic)
-25.96-42.39-45.32-13.88-19.68-47.50-13.88-5.96-
Diluted Shares Outstanding
2.03M2.06M4.95M12.7M13.71M14.21M15M16.05M16.59M
Basic Shares Outstanding
2.03M2.06M4.95M12.7M13.71M14.21M15M16.05M16.59M
Dividend Payout Ratio
---------

AMWL Balance Sheet

American Well Corporation (AMWL) balance sheet — assets, liabilities & shareholders' equity

MetricDec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Current Assets
300.17M223.53M1.11B827.3M626.62M449.58M316.99M246.68M259.05M
Cash & Short-Term Investments
256.2M177.63M1.04B746.42M538.55M372.04M228.32M182.33M179.21M
Cash Only
47.98M137.67M941.62M746.42M538.55M372.04M228.32M182.33M179.21M
Short-Term Investments
208.23M39.95M99.96M000000
Accounts Receivable
30.78M32.73M45.3M51.38M58.37M54.15M71.89M49.69M57.09M
Days Sales Outstanding
98.5880.2567.4174.1876.8676.29103.1572.75107.96
Inventory
2.51M3.1M9.13M7.53M8.74M6.65M2.86M1.19M1.15M
Days Inventory Outstanding
15.6414.1721.2518.5119.8814.786.713.725.18
Other Current Assets
5.87M2.91M3.23M1.7M1.39M16.75M13.93M13.47M21.6M
Total Non-Current Assets
189.15M276.35M263.36M618.54M590.94M140.12M118.97M77.11M66.92M
Property, Plant & Equipment
3.08M14.61M10.45M18.66M14.52M11.03M7.58M4.16M178K
Fixed Asset Turnover
37.03x10.19x23.48x13.55x19.09x23.50x33.56x60.01x47.95x
Goodwill
127.27M193.88M193.88M442.76M435.28M0000
Intangible Assets
55.39M63.53M55.53M152.41M134.98M120.25M101.54M66.07M61.09M
Long-Term Investments
00752K168K795K1.18M1.5M795K3.38M
Other Non-Current Assets
4.5M5.48M1.43M2.52M6.16M7.67M8.36M6.08M5.65M
Total Assets
489.31M▲ 0%
499.88M▲ 2.2%
1.38B▲ 175.4%
1.45B▲ 5.0%
1.22B▼ 15.8%
589.71M▼ 51.6%
435.97M▼ 26.1%
323.79M▼ 25.7%
325.97M▲ 0%
Asset Turnover
0.23x0.30x0.18x0.17x0.23x0.44x0.58x0.77x0.52x
Asset Growth %
-2.16%175.39%5.03%-15.79%-51.57%-26.07%-25.73%-97.07%
Total Current Liabilities
87.83M106.58M120.98M141.63M114.06M93.8M111.26M73.21M83.77M
Accounts Payable
4.23M6.5M5.8M12.16M7.24M4.86M5.01M1.65M1.39M
Days Payables Outstanding
26.3229.6813.529.8816.4610.8111.785.1710.39
Short-Term Debt
000000003.96M
Deferred Revenue (Current)
64.13M00049.51M46.37M53.23M22.63M122.84M
Other Current Liabilities
8.3M66.49M66.69M83.84M35.97M12.14M36.07M34.73M48.76M
Current Ratio
3.42x2.10x9.20x5.84x5.49x4.79x2.85x3.37x3.09x
Quick Ratio
3.39x2.07x9.13x5.79x5.42x4.72x2.82x3.35x3.08x
Cash Conversion Cycle
87.9164.7475.1662.8180.2880.2698.0971.3102.75
Total Non-Current Liabilities
605.89M18.37M9.47M43.34M19.65M15.72M8.46M2.79M2.07M
Long-Term Debt
000000000
Capital Lease Obligations
07.16M1.3M14.69M11.79M8.21M4.51M892K5.36M
Deferred Tax Liabilities
000000000
Other Non-Current Liabilities
576.72M11.21M64K21.59M1.57M1.43M1.17M1.07M2.07M
Total Liabilities
693.72M124.95M130.45M184.96M133.71M109.52M119.72M76M85.84M
Total Debt
013.4M7.65M16.61M14.84M11.79M8.2M4.52M3.96M
Net Debt
-47.98M-124.28M-933.96M-729.8M-523.7M-360.25M-220.12M-177.8M-175.25M
Debt / Equity
-0.04x0.01x0.01x0.01x0.02x0.03x0.02x0.02x
Debt / EBITDA
---------0.07x
Net Debt / EBITDA
--------2.99x
Interest Coverage
---------239.18x
Total Equity
371.3M▲ 0%
374.94M▲ 1.0%
1.25B▲ 232.4%
1.26B▲ 1.2%
1.08B▼ 14.0%
480.19M▼ 55.7%
316.24M▼ 34.1%
247.79M▼ 21.6%
240.12M▲ 0%
Equity Growth %
-0.98%232.38%1.18%-14.04%-55.7%-34.14%-21.65%-88.78%
Book Value per Share
182.98182.28251.6499.2579.0433.7921.0815.4414.47
Total Shareholders' Equity
343.87M348.68M1.22B1.24B1.06B464.22M304.77M235.58M227.33M
Common Stock
49K423K2.36M2.62M2.77M145K156K165K167K
Retained Earnings
-270.74M-357.93M-582.36M-811.28M-1.08B-1.76B-1.97B-2.06B-2.07B
Treasury Stock
0-158K-37.57M000000
Accumulated OCI
1.35M250K297K-6.35M-16.97M-15.65M-15.84M-12.1M-12.07M
Minority Interest
27.43M26.26M22.07M21.62M19.97M15.97M11.47M12.21M12.79M

AMWL Cash Flow Statement

American Well Corporation (AMWL) cash flow — operating, investing & free cash flow history

MetricDec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations
-74.01M-81.89M-112.46M-141.54M-192.32M-148.34M-127.34M-65.95M-41.83M
Operating CF Margin %
-64.94%-55.01%-45.85%-55.99%-69.38%-57.26%-50.06%-26.45%-
Operating CF Growth %
--10.66%-37.33%-25.85%-35.88%22.87%14.16%48.21%187.23%
Net Income
-52.31M-88.37M-228.63M-176.78M-272.07M-675.16M-208.14M-95.7M-87.88M
Depreciation & Amortization
5.33M7.76M10.15M16.09M26.17M31.92M33.43M33.96M34.69M
Stock-Based Compensation
7.67M12.13M118.36M43.81M67.67M72.25M022.01M16.98M
Deferred Taxes
884K-1.39M3.83M-6.25M-2.52M-242K-243K-1.11M-39K
Other Non-Cash Items
1.19M2.49M2.26M9.31M16.53M438.4M57.59M1.68M7.27M
Working Capital Changes
-36.77M-14.52M-18.45M-27.71M-28.1M-15.51M-9.98M-26.8M-14.06M
Change in Receivables
-19.47M803K-14.21M-512K-8.14M3.25M-25.01M12.22M9.89M
Change in Inventory
1.57M-592K-6.02M1.6M-1.21M2.08M1.9M1.17M882K
Change in Payables
-787K1.16M-707K5.55M-4.78M-2.36M159K-3.42M-5.11M
Cash from Investing
-245.93M120M-66.76M-59.63M-11.63M-19.17M-18.65M17.1M-5.07M
Capital Expenditures
-1.91M-1.34M-3.32M-559K-10.45M-292K0-21K-17K
CapEx % of Revenue
1.68%0.9%1.35%0.22%3.77%0.11%5.98%0.01%0.01%
Acquisitions
-64.38M-45.75M-2.94M-159.07M-1.96M0018.32M-2.08M
Investments
---------
Other Investing
000-2.55M0-18.88M-18.65M-196K-2.78M
Cash from Financing
278.18M46.64M983.12M5.75M-3.61M2.15M1.38M840K600K
Debt Issued (Net)
000000000
Equity Issued (Net)
277.55M45.6M980.48M-15.04M-360K-586K-3K840K297K
Dividends Paid
000000000
Share Repurchases
-2.9M-158K-37.57M-15.04M-360K-586K-3K-4K-3K
Other Financing
635K1.04M2.64M20.79M-3.25M2.73M1.38M0303K
Net Change in Cash
-41.76M▲ 0%
84.75M▲ 302.9%
803.89M▲ 848.6%
-195.5M▼ 124.3%
-207.87M▼ 6.3%
-166.51M▲ 19.9%
-143.72M▲ 13.7%
-45.99M▲ 68.0%
-43.2M▲ 0%
Free Cash Flow
-75.92M▲ 0%
-83.23M▼ 9.6%
-115.78M▼ 39.1%
-142.1M▼ 22.7%
-202.77M▼ 42.7%
-163.59M▲ 19.3%
-142.56M▲ 12.9%
-65.97M▲ 53.7%
-41.84M▲ 0%
FCF Margin %
-66.62%-55.91%-47.21%-56.21%-73.15%-63.15%-56.05%-26.46%-22.93%
FCF Growth %
--9.63%-39.11%-22.73%-42.7%19.32%12.86%53.72%60.16%
FCF per Share
-37.41-40.46-23.38-11.19-14.79-11.51-9.50-4.11-2.52
FCF Conversion (FCF/Net Income)
1.40x0.94x0.50x0.80x0.71x0.22x0.61x0.69x0.48x
Interest Paid
000000000
Taxes Paid
0193K713K1.59M1.72M5M4.11M0686K

AMWL Key Ratios

American Well Corporation (AMWL) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric2019202020212022202320242025TTM
Return on Equity (ROE)
-23.37%-27.69%-14.07%-23.07%-86.34%-52.27%-33.93%-33.48%
Return on Invested Capital (ROIC)
-24.75%-60.61%-31.86%-37.92%-152.66%-151.02%-95.06%-95.9%
Gross Margin
46.27%36.07%41.27%42.13%36.58%38.9%53.29%38.73%
Net Margin
-58.57%-91.51%-69.76%-97.56%-260.63%-81.83%-38.38%-48.16%
Debt / Equity
0.04x0.01x0.01x0.01x0.02x0.03x0.02x0.02x
Interest Coverage
--------239.18x
FCF Conversion
0.94x0.50x0.80x0.71x0.22x0.61x0.69x0.48x
Revenue Growth
30.63%64.77%3.07%9.65%-6.55%-1.81%-1.98%-30.26%
Related:AMWL Dividend History·AMWL Revenue History·AMWL Price History·AMWL P/E History·AMWL Financial Ratios·AMWL Institutional Holders

AMWL SEC Filings & Documents

American Well Corporation (AMWL) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 5, 2026·SEC

Material company update

Apr 2, 2026·SEC

Material company update

Feb 12, 2026·SEC

10-K Annual Reports

3
FY 2026

Feb 12, 2026·SEC

FY 2025

Feb 12, 2025·SEC

FY 2024

Feb 15, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

May 5, 2026·SEC

FY 2025

Nov 4, 2025·SEC

FY 2025

Aug 5, 2025·SEC

AMWL Frequently Asked Questions

American Well Corporation (AMWL) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

American Well Corporation (AMWL) reported $182.5M in revenue for fiscal year 2025. This represents a 60% increase from $114.0M in 2018.

American Well Corporation (AMWL) saw revenue decline by 2.0% over the past year.

American Well Corporation (AMWL) reported a net loss of $87.9M for fiscal year 2025.

Dividend & Returns

American Well Corporation (AMWL) has a return on equity (ROE) of -33.9%. Negative ROE indicates the company is unprofitable.

American Well Corporation (AMWL) had negative free cash flow of $41.8M in fiscal year 2025, likely due to heavy capital investments.

What if you invested $1,000 in AMWL back in 2018?

Total return calculator · dividends reinvested · 8+ years of data

See returns →

How much would $100/month in AMWL be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →